Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 4Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1Liver Metastases 1

Interventions

pembrolizumab 409Cyclophosphamide 398Carboplatin 307Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 209Bevacizumab 207fludarabine 195Docetaxel 186Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 121Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Electrochemotherapy × Clear all
NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed
25 enrolled 6 charts
Gastrointestinal

Liver Neoplasms

NCT01264952 2020-11-24

ECTJ

Institute of Oncology Ljubljana

Phase 1/2 Completed
16 enrolled 9 charts

Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡